Renasant Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$372K Buy
4,312
+166
+4% +$14.6K 0.25% 95
2026
Q2
$324K Buy
4,146
+1,011
+32% +$81.6K 0.21% 107
2026
Q1
$272K Buy
3,135
+664
+27% +$63.6K 0.19% 115
2025
Q4
$237K Hold
2,471
– – 0.16% 127
2025
Q3
$235K Sell
2,471
-16
-0.6% -$1.47K 0.15% 131
2025
Q2
$217K Sell
2,487
-898
-27% -$76.2K 0.14% 141
2025
Q1
$304K Buy
3,385
+236
+7% +$21.1K 0.2% 118
2024
Q4
$252K Sell
3,149
-521
-14% -$45.1K 0.16% 140
2024
Q3
$330K Sell
3,670
-579
-14% -$48.7K 0.22% 122
2024
Q2
$334K Buy
4,249
+1,467
+53% +$120K 0.23% 110
2024
Q1
$242K Sell
2,782
-657
-19% -$56.1K 0.17% 149
2023
Q4
$283K Sell
3,439
-764
-18% -$58.2K 0.23% 126
2023
Q3
$329K Buy
4,203
+466
+12% +$39K 0.28% 110
2023
Q2
$329K Buy
3,737
+42
+1% +$3.62K 0.27% 118
2023
Q1
$298K Buy
3,695
+287
+8% +$23.4K 0.23% 139
2022
Q4
$265K Buy
+3,408
New +$276K 0.2% 158

Other funds holding MDT

Renasant Bank's MDT Position: Q3 2026 in Review

Renasant Bank increased its Medtronic (MDT) stake by 4% in Q3 2026, buying an estimated $14.6K and bringing the position to 4,312 shares worth $372K. The position accounts for 0.25% of the portfolio, ranked #95.

Renasant Bank first reported a position in MDT in Q4 2022 and has held it in 16 quarters since. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Renasant Bank held 4,312 shares of Medtronic worth $372K as of Q3 2026.
  • Renasant Bank bought 166 Medtronic shares in Q3 2026, an estimated $14.6K.
  • Medtronic made up 0.25% of Renasant Bank's portfolio in Q3 2026, its #95 holding.
  • Renasant Bank first reported a position in Medtronic in Q4 2022 and has held it in 16 quarters since.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Renasant Bank's 13F filing for Q3 2026, filed 5 Nov 2026.